Queilitis comisural como forma de presentación de una leishmaniasis cutánea crónica

Canaval Parra, LF; Rosa Salazar, V; Martínez Menchón, T; García Pérez, B.
Rev. clín. esp. (Ed. impr.) ; 216(1): 48-48, ene.-feb. 2016. ilus
Artículo en Español | IBECS (España) | ID: ibc-149735

Documentos relacionados

  1. Interplay of Trypanosome Lytic Factor and innate immune cells in the resolution of cutaneous Leishmania infection.
  2. CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
  3. Chronic amastigote-negative cutaneous leishmaniasis: A clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentations.
  4. The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis.
  5. The EP3662 clone of CD1a supports the diagnosis of New World cutaneous leishmaniasis.
  6. Localized Leishmania major infection disrupts systemic iron homeostasis that can be controlled by oral iron supplementation.
  7. New Insights on Heme Uptake in <i>Leishmania</i> spp.
  8. Sterol 14-&#945;-demethylase is vital for mitochondrial functions and stress tolerance in Leishmania major.
  9. [Cutaneous leishmaniasis].
  10. DC-SIGN receptor is expressed by cells from cutaneous leishmaniasis lesions and differentially binds to Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis promastigotes.